Bone turnover markers and BMD remain elevated in postmenopausal osteoporotic women through a full 24 months of treatment with human parathyroid hormone 1-84 (PTH).

被引：0
|
作者：
Greenspan, S. L.
Hanley, D. A.
Morris, S.
Marriott, T. B.
机构：
[1] Univ Pittsburgh, Osteoporosis Prevent & Treatment Ctr, Pittsburgh, PA 15260 USA
[2] Univ Calgary, Calgary, AB T2N 1N4, Canada
[3] NPS Pharmaceut Inc, Parsippany, NJ USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [1] Efficacy of full-length parathyroid hormone PTH(l-84) in postmenopausal osteoporotic women through 24 months of treatment
    Roman-Ivorra, J.
    Comella, N. Fernandez-Llanio
    Chalmeta-Verdejo, C.
    Greisen, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 532 - 532
  • [2] Changes in bone turnover markers and BMD in women with osteoporosis after PTH 1-84 treatment
    Pastore, R.
    Mentuccia, D.
    Borboni, P.
    Frajese, V.
    [J]. BONE, 2009, 44 (02) : S440 - S441
  • [3] Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women
    Adami, Silvano
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3259 - 3274
  • [4] Safety and efficacy of 36 months treatment of postmenopausal osteoporotic women with PTH (1-84)
    Recker, R. R.
    Zanchetta, J. R.
    Mautalen, C. A.
    Man, Z.
    Leib, E. S.
    Morris, S. A.
    Greisen, H.
    Fox, J.
    [J]. BONE, 2009, 44 (02) : S431 - S431
  • [5] Treatment of postmenopausal osteoporotic women with parathyroid hormone (1-84) for 18 months decreases BMD but does not affect indices of bone strength at the distal radius.
    Bogado, C. E.
    Zanchetta, J. R.
    Gordon, C. L.
    Bouxsein, M. L.
    Mathisen, A. L.
    Fox, J.
    Morris, S.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S112 - S113
  • [6] Treatment of osteoporotic women with parathyroid hormone (1-84) for 24 months improves cancellous bone formation and structure: A bone biopsy study
    Lems, Willem F.
    Geusens, Piet
    Recker, Robert R.
    Bare, Susan P.
    Miller, Michael A.
    Greisen, Hanna
    Fox, John
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S738 - S738
  • [7] Full length parathyroid hormone (1-84) in the treatment of osteoporosis in postmenopausal women
    Jodar-Gimeno, Esteban
    [J]. CLINICAL INTERVENTIONS IN AGING, 2007, 2 (01) : 163 - 174
  • [8] Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84
    Recker, R. R.
    Bare, S. R.
    Smith, S. Y.
    Varela, A.
    Miller, M. A.
    Morris, S. A.
    Fox, J.
    [J]. BONE, 2009, 44 (01) : 113 - 119
  • [9] Continued increase in hip BMD after 36 months of PTH(1-84) treatment in postmenopausal, women
    Jodar-Gimeno, E.
    Leib, E. S.
    Zanchetta, J. R.
    Mautalen, C. A.
    Greisen, H.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S231 - S231
  • [10] Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis
    Black, D. M.
    Bilezikian, J. P.
    Greenspan, S. L.
    Wuester, C.
    Munoz-Torres, M.
    Bone, H. G.
    Rosen, C. J.
    Andersen, H. S.
    Hanley, D. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 (04) : 1503 - 1511
12345